Blackrock Ventures


We provide First in Class Investor Relations Services

Our Offering

Mission Our mission is to deliver effective, efficient and value adding services to our clients and suppliers.

Vision Our Vision is to become the “ go to “ team for companies expanding in Europe and North America.

Values Our Values are whom we are as people, ethical, success driven, and humble.

Global Bespoke Investor Relations



Since 2018, we have engaged Blackrock Ventures Investor Relations (BVIR) to support our Company’s awareness, growth and relationships. As a regulated pharmaceutical company, we place a high priority on working with ethical professionals, and we are pleased to be associated with BVIR.  Not only did BVIR, and Peter O’Brien specifically, bring to us a significant number of investors in the early financing rounds, BVIR has continued to provide support through our listing on the Nasdaq in June 2019 and beyond.  We were very pleased when BVIR went above and beyond traditional investor relations services in making several introductions that ultimately led to new research collaborations and recruitment of scientists now employed at our company.  We continue to rely upon BVIR for IR in Europe and look forward to the breadth of contributions Peter and his team are anticipated to provide as we advance our development programmes.

Greg Gorgas
CEO Artelo Biosciences